George Washington University School of Public Health, Washington, DC.
Department of Health Policy and Management, School of Public Health, The George Washington University, 950 New Hampshire Ave NW, Washington, DC 20052-0086. Email:
Prev Chronic Dis. 2022 Mar 3;19:E10. doi: 10.5888/pcd19.210280.
Health system disruption caused by the COVID-19 pandemic prompted public health professionals to reevaluate potential barriers and opportunities to community pharmacist provision of chronic disease management services and to identify opportunities for maximizing community pharmacists' impact. Researchers conducted semistructured interviews with representatives from chronic disease prevention and pharmacy practice and policy organizations to identify key themes across multiple interviews and novel responses of interest. Interviewees described a lack of payment models to support pharmacist-provided chronic disease management services but noted opportunities for community pharmacists to demonstrate their value in offering services they are uniquely positioned to provide and to implement better workflow solutions. Successfully demonstrating pharmacists' value and making the case for reimbursement from payors, as well as optimizing pharmacy workflow, are critical to maximizing pharmacists' impact in chronic disease prevention and management.
由 COVID-19 大流行引起的卫生系统混乱促使公共卫生专业人员重新评估社区药剂师提供慢性病管理服务的潜在障碍和机会，并确定最大限度发挥社区药剂师影响力的机会。研究人员对慢性病预防和药房实践及政策组织的代表进行了半结构化访谈，以确定多个访谈中的关键主题和新出现的相关问题。受访者表示，缺乏支付模式来支持药剂师提供的慢性病管理服务，但指出社区药剂师有机会通过提供他们具有独特优势的服务来展示其价值，并实施更好的工作流程解决方案。成功地展示药剂师的价值并为支付方的报销提出理由，以及优化药房工作流程，对于最大限度地提高药剂师在慢性病预防和管理方面的影响力至关重要。
